麻豆传媒

Study paves the way for quadruple therapy in patients not eligible for a stem cell transplant

Reduced toxicity and improved convenience position new treatments for broader use

Rapid evaluation and novel therapies may improve outcomes for these patients

Experts at ASH debate quadruplet therapy, dexamethasone modulation, and novel approaches

Study links strong relationships to better physical and emotional outcomes in myeloma care

Longer gaps between anti-BCMA agents associated with improved response rates, study finds

Phase III trial sparks discussion on defining and managing high-risk smoldering myeloma

DREAMM-7 findings help pave the way for Blenrep's return

Higher response rate, PFS, OS with cilta-cel, but ide-cel had lower rate of severe toxicity

Daratumumab significantly improved PFS, OS, but identity of high-risk population remains elusive

High-fiber diets tied to improved outcomes in stem-cell transplants, slowing myeloma precursors

A drug comeback, new FDA approvals, and a new standard for transplant-ineligible patients

News, features, and commentary about cancer-related issues

News, features, and commentary about cancer-related issues